PURE Bioscience, Inc.
PURE
$0.0653
$0.00538.83%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -9.48% | -15.55% | 4.58% | 23.95% | 14.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.48% | -15.55% | 4.58% | 23.95% | 14.02% |
| Cost of Revenue | -15.64% | -21.60% | -10.49% | -3.46% | 0.88% |
| Gross Profit | -4.49% | -10.47% | 18.64% | 57.22% | 27.50% |
| SG&A Expenses | -12.21% | -10.00% | -7.46% | -3.98% | -3.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.15% | -11.62% | -7.47% | -3.47% | -3.05% |
| Operating Income | 13.84% | 9.13% | 13.70% | 15.65% | 11.42% |
| Income Before Tax | 14.95% | 10.78% | 15.43% | 12.88% | 9.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 14.95% | 10.78% | 15.43% | 12.88% | 9.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.95% | 10.78% | 15.43% | 12.88% | 9.91% |
| EBIT | 13.84% | 9.13% | 13.70% | 15.65% | 11.42% |
| EBITDA | 13.99% | 10.22% | 15.04% | 15.54% | 10.66% |
| EPS Basic | 15.24% | 10.81% | 15.45% | 17.88% | 18.81% |
| Normalized Basic EPS | 8.60% | 4.23% | 9.80% | 17.41% | 18.78% |
| EPS Diluted | 15.24% | 10.81% | 15.45% | 17.88% | 18.81% |
| Normalized Diluted EPS | 8.60% | 4.23% | 9.80% | 17.41% | 18.78% |
| Average Basic Shares Outstanding | 0.18% | 0.29% | 0.41% | 4.91% | 10.89% |
| Average Diluted Shares Outstanding | 0.18% | 0.29% | 0.41% | 4.91% | 10.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |